Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Evidity Health Capital, founded in 2014 and originally known as Canepa Healthcare, operates from New York and Miami. The firm specializes in late-stage venture capital and growth equity, focusing on private medical technology companies that have commercialized products. They typically manage investments of at least $5 million and aim to support companies in achieving profitability.
The firm invests in sectors such as medical devices, digital health, and in vitro diagnostics. Evidity Health Capital targets companies that have received regulatory clearance in the U.S. and are expected to experience rapid revenue growth within 3-5 years. They are flexible in their investment approach, considering both controlling and minority stakes while emphasizing active involvement to enhance value.
Notable companies in Evidity Health Capital's portfolio include Augmedics, Inc., which develops augmented reality technologies for surgical applications; GT Medical Technologies, Inc., known for GammaTile® Therapy for localized radiation therapy; and Magnolia Medical Technologies, Inc., which creates blood collection devices for accurate diagnostic tests. Other portfolio companies include Poseidon Medical, Inc., PreludeDx, Inc., and Sonde Health, Inc..
Submit your pitch through their website's contact form or email them directly with your deck for consideration.
Evidity Health Capital focuses on late-stage medical technology companies that have achieved regulatory clearance and are positioned for rapid revenue growth. They typically invest at least $5 million and prefer to take an active role in their portfolio companies.
Yes, the firm is open to leading investment rounds, particularly when they see an opportunity to add value through active involvement.
The firm prefers companies in the healthcare sector, specifically in medical devices, digital health, and in vitro diagnostics, that have already commercialized products and are seeking growth capital.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.